| Position statement | Class | References |
|---|---|---|
| Wearable devices (smartphones and smartwatches) with PPG sensors may be used for AF screening providing appropriate and approved software applications are installed and utilized. |  | 59–63,66 |
| When a screening test suggests a diagnosis of AF, ECG confirmation of at least 30 s duration is required. |  | 10 |
| Diagnosis via wearables without the capability of ECG recording should not guide the therapy/anticoagulation management. |  | 10 |
| Position statement | Class | References |
|---|---|---|
| Wearable devices (smartphones and smartwatches) with PPG sensors may be used for AF screening providing appropriate and approved software applications are installed and utilized. | | 59–63,66 |
| When a screening test suggests a diagnosis of AF, ECG confirmation of at least 30 s duration is required. | | 10 |
| Diagnosis via wearables without the capability of ECG recording should not guide the therapy/anticoagulation management. | | 10 |
| Position statement | Class | References |
|---|---|---|
| Wearable devices (smartphones and smartwatches) with PPG sensors may be used for AF screening providing appropriate and approved software applications are installed and utilized. | | 59–63,66 |
| When a screening test suggests a diagnosis of AF, ECG confirmation of at least 30 s duration is required. | | 10 |
| Diagnosis via wearables without the capability of ECG recording should not guide the therapy/anticoagulation management. | | 10 |
| Position statement | Class | References |
|---|---|---|
| Wearable devices (smartphones and smartwatches) with PPG sensors may be used for AF screening providing appropriate and approved software applications are installed and utilized. | | 59–63,66 |
| When a screening test suggests a diagnosis of AF, ECG confirmation of at least 30 s duration is required. | | 10 |
| Diagnosis via wearables without the capability of ECG recording should not guide the therapy/anticoagulation management. | | 10 |
